BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pawel BR. SMARCB1-deficient Tumors of Childhood: A Practical Guide. Pediatr Dev Pathol 2018;21:6-28. [PMID: 29280680 DOI: 10.1177/1093526617749671] [Cited by in Crossref: 61] [Cited by in F6Publishing: 60] [Article Influence: 12.2] [Reference Citation Analysis]
Number Citing Articles
1 Zhuang HH, Qu Q, Teng XQ, Dai YH, Qu J. Superenhancers as master gene regulators and novel therapeutic targets in brain tumors. Exp Mol Med 2023;55:290-303. [PMID: 36720920 DOI: 10.1038/s12276-023-00934-0] [Reference Citation Analysis]
2 Fierro Pineda JC, Wedekind MF, Glod JW. Immunotherapy approaches for rare pediatric solid tumors: advances and future directions. Curr Opin Pediatr 2023;35:63-74. [PMID: 36420774 DOI: 10.1097/MOP.0000000000001206] [Reference Citation Analysis]
3 Rottmann D, Abdulfatah E, Pantanowitz L. Molecular testing of soft tissue tumors. Diagn Cytopathol 2023;51:12-25. [PMID: 35808975 DOI: 10.1002/dc.25013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Dermawan JK, Singer S, Tap WD, Nacev BA, Chi P, Wexler LH, Ortiz MV, Gounder M, Antonescu CR. The genetic landscape of SMARCB1 alterations in SMARCB1-deficient spectrum of mesenchymal neoplasms. Mod Pathol 2022;35:1900-9. [PMID: 36088476 DOI: 10.1038/s41379-022-01148-x] [Reference Citation Analysis]
5 Krasniqi E, Goeman F, Pulito C, Palcau AC, Ciuffreda L, Di Lisa FS, Filomeno L, Barba M, Pizzuti L, Cappuzzo F, Sanguineti G, Maugeri-Saccà M, Ciliberto G, Fanciulli M, Blandino G, Vici P. Biomarkers of Response and Resistance to CDK4/6 Inhibitors in Breast Cancer: Hints from Liquid Biopsy and microRNA Exploration. Int J Mol Sci 2022;23. [PMID: 36498861 DOI: 10.3390/ijms232314534] [Reference Citation Analysis]
6 Yasue S, Ozeki M, Endo S, Kanayama T, Suzui N, Nakamura S, Kishimoto K, Kosaka Y, Miyazaki T, Demizu Y, Soejima T, Kawamura A, Ohnishi H. Poorly Differentiated Chordoma of the Clivus With Loss of SMARCB1 Expression in a Pediatric Patient: A Case Report. J Pediatr Hematol Oncol 2022;44:465-70. [PMID: 35091519 DOI: 10.1097/MPH.0000000000002402] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Hahn AW, Lebenthal J, Genovese G, Sircar K, Tannir NM, Msaouel P. The significance of sarcomatoid and rhabdoid dedifferentiation in renal cell carcinoma. Cancer Treat Res Commun 2022;33:100640. [PMID: 36174377 DOI: 10.1016/j.ctarc.2022.100640] [Reference Citation Analysis]
8 Brodie Z, Mccartney E, Toledo S. An Adrenal SMARCB1/INI1 Deficient Proximal Epithelioid Sarcoma in a Middle-Aged Female: A Case Report. Cureus 2022. [DOI: 10.7759/cureus.29242] [Reference Citation Analysis]
9 Karele EN, Paze AN. Chordoma: To know means to recognize. Biochim Biophys Acta Rev Cancer 2022;1877:188796. [PMID: 36089204 DOI: 10.1016/j.bbcan.2022.188796] [Reference Citation Analysis]
10 Krishnamurthy N, Kato S, Lippman S, Kurzrock R. Chromatin remodeling (SWI/SNF) complexes, cancer, and response to immunotherapy. J Immunother Cancer 2022;10:e004669. [DOI: 10.1136/jitc-2022-004669] [Reference Citation Analysis]
11 Tung S, Heffernan J, Morton SU, Aziz-Bose R, Estroff JA. Fetal Disseminated Malignant Rhabdoid Tumor. Neoreviews 2022;23:e595-602. [PMID: 35909108 DOI: 10.1542/neo.23-8-e595] [Reference Citation Analysis]
12 Kerper AL, Clarke-Brodber AL, Gupta S, Whalen KM, Nigdelioglu R, Boland JM, Schembri Wismayer DJ, Torres-Mora J, Mejia Acevedo MR, Sudhindran V, Sturgis CD. Malignant rhabdoid tumor: Cyto-histologic correlation and immunohistochemical characterization of a rare pediatric malignancy and its differential diagnoses. Ann Diagn Pathol 2022;60:152014. [PMID: 35905536 DOI: 10.1016/j.anndiagpath.2022.152014] [Reference Citation Analysis]
13 Su Y, Hong AL. Recent Advances in Renal Medullary Carcinoma. IJMS 2022;23:7097. [DOI: 10.3390/ijms23137097] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Mikkilineni N, Rodrigues Pessoa R, Cost CR, Doughty E, Treece AL, Cost NG. Extrarenal, Soft Tissue Malignant Rhabdoid Tumor arising in the Mons Pubis. Urology 2022. [DOI: 10.1016/j.urology.2022.03.040] [Reference Citation Analysis]
15 Katsumi Y, Iehara T, Kuwahara Y, Tsuchiya K, Konishi E, Hosoi H. Diverse outcomes in extra-cranial rhabdoid tumors: A single institute experience. Pediatr Hematol Oncol 2022;39:278-85. [PMID: 34668815 DOI: 10.1080/08880018.2021.1986614] [Reference Citation Analysis]
16 Florian AC, Woodley CM, Wang J, Grieb BC, Slota MJ, Guerrazzi K, Hsu CY, Matlock BK, Flaherty DK, Lorey SL, Fesik SW, Howard GC, Liu Q, Weissmiller AM, Tansey WP. Synergistic action of WDR5 and HDM2 inhibitors in SMARCB1-deficient cancer cells. NAR Cancer 2022;4:zcac007. [PMID: 35252869 DOI: 10.1093/narcan/zcac007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Vujanić G, Đuričić S. Renal tumours of childhood: A review. Scripta Medica 2022;53:337-345. [DOI: 10.5937/scriptamed53-38283] [Reference Citation Analysis]
18 Berger-saunderson M, Cordova EJ, Pérez-bañuelos A, Peralta-velázquez V, Angeles-romero AA, Sanchez A, Vega-vega L, Escamilla-asiain G, Esmer C. Molecular diagnostic challenges in a case with atypical teratoid tumor: Case report. Current Problems in Cancer: Case Reports 2021;4:100122. [DOI: 10.1016/j.cpccr.2021.100122] [Reference Citation Analysis]
19 Mao R, Liu M, Shu X, Li W, Yan W, Li X. Expanding the Immunophenotype Spectrum of SMARCA4-Deficient Non-Small Cell Lung Carcinomas: A Case Series with Neuroendocrine Markers Expression. Int J Surg Pathol 2021;:10668969211047982. [PMID: 34633874 DOI: 10.1177/10668969211047982] [Reference Citation Analysis]
20 Slack JC, Church AJ. Molecular Alterations in Pediatric Solid Tumors. Surg Pathol Clin 2021;14:473-92. [PMID: 34373097 DOI: 10.1016/j.path.2021.05.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Gupta S, Srinivasan R, Trehan A, Rohilla M, Kakkar N, Bansal D, Dey P, Gupta N, Gupta P, Gupta K, Saxena A, Menon P, Rajwanshi A. Diagnostic accuracy and cytomorphological spectrum of Wilms tumour in fine needle aspiration biopsy cytology samples supplemented with cell blocks. Pediatr Blood Cancer 2021;68:e28996. [PMID: 33745231 DOI: 10.1002/pbc.28996] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
22 Gradecki SE, Kelting SM, Stelow EB. SMARCB1 (INI1)–Deficient Sinonasal Carcinoma With Yolk Sac Tumor Differentiation: Case Report and Review of the Literature. AJSP: Reviews and Reports 2021;26:259-263. [DOI: 10.1097/pcr.0000000000000456] [Reference Citation Analysis]
23 Liu H, Bruner ET, Yang J. Cytologic features of malignant rhabdoid tumor of the liver: A case report and literature review. Diagn Cytopathol 2021;49:E364-9. [PMID: 34171176 DOI: 10.1002/dc.24815] [Reference Citation Analysis]
24 Alturkustani M, Schmidt R, Gayer C, Warren M, Navid F, Raca G, Biegel JA, Pawel B, Zhou S. Primary Adrenal Malignant Rhabdoid Tumor in a 14-Year-Old Female: A Case Report and Literature Review. Int J Surg Pathol 2021;:10668969211024331. [PMID: 34106024 DOI: 10.1177/10668969211024331] [Reference Citation Analysis]
25 Blattner-Johnson M, Jones DTW, Pfaff E. Precision medicine in pediatric solid cancers. Semin Cancer Biol 2021:S1044-579X(21)00178-4. [PMID: 34116162 DOI: 10.1016/j.semcancer.2021.06.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
26 Parker NA, Al-Obaidi A, Deutsch JM. SMARCB1/INI1-deficient tumors of adulthood. F1000Res 2020;9:662. [PMID: 33796273 DOI: 10.12688/f1000research.24808.2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
27 Polifka I, Agaimy A, Moch H, Hartmann A. [Histological subtypes of renal cell carcinoma : Overview and new developments]. Pathologe 2021;42:294-304. [PMID: 33825093 DOI: 10.1007/s00292-021-00937-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Horton RK, Ahadi M, Gill AJ, Said S, Chen ZE, Bakhshwin A, Nichols M, Goldblum JR, Graham RP. SMARCA4/SMARCA2-deficient Carcinoma of the Esophagus and Gastroesophageal Junction. Am J Surg Pathol 2021;45:414-20. [PMID: 33027072 DOI: 10.1097/PAS.0000000000001599] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
29 Hui Y, Cotzia P, Rana S, Kezlarian BE, Lin O, Hollmann TJ, Dogan S. Primary cutaneous SMARCB1-deficient carcinoma. J Cutan Pathol 2021;48:1051-60. [PMID: 33625734 DOI: 10.1111/cup.13996] [Reference Citation Analysis]
30 Bai J, Shi J, Li C, Wang S, Zhang T, Hua X, Zhu B, Koka H, Wu HH, Song L, Wang D, Wang M, Zhou W, Ballew BJ, Zhu B, Hicks B, Mirabello L, Parry DM, Zhai Y, Li M, Du J, Wang J, Zhang S, Liu Q, Zhao P, Gui S, Goldstein AM, Zhang Y, Yang XR. Whole genome sequencing of skull-base chordoma reveals genomic alterations associated with recurrence and chordoma-specific survival. Nat Commun 2021;12:757. [PMID: 33536423 DOI: 10.1038/s41467-021-21026-5] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 15.0] [Reference Citation Analysis]
31 Frühwald MC, Nemes K, Boztug H, Cornips MCA, Evans DG, Farah R, Glentis S, Jorgensen M, Katsibardi K, Hirsch S, Jahnukainen K, Kventsel I, Kerl K, Kratz CP, Pajtler KW, Kordes U, Ridola V, Stutz E, Bourdeaut F. Current recommendations for clinical surveillance and genetic testing in rhabdoid tumor predisposition: a report from the SIOPE Host Genome Working Group. Fam Cancer 2021. [PMID: 33532948 DOI: 10.1007/s10689-021-00229-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
32 Matsumura N, Goda N, Yashige K, Kitagawa M, Yamazaki T, Nobusawa S, Yokoo H. Desmoplastic myxoid tumor, SMARCB1-mutant: a new variant of SMARCB1-deficient tumor of the central nervous system preferentially arising in the pineal region. Virchows Arch 2021. [PMID: 33420834 DOI: 10.1007/s00428-020-02978-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
33 Mocellin S. Rhabdoid Tumor. Soft Tissue Tumors 2021. [DOI: 10.1007/978-3-030-58710-9_222] [Reference Citation Analysis]
34 Biegel JA, Roth JJ. Rhabdoid Tumors. The Hereditary Basis of Childhood Cancer 2021. [DOI: 10.1007/978-3-030-74448-9_3] [Reference Citation Analysis]
35 Harbaugh K, Patel NT, Rizk E. Genetics of Nerve Tumors. Diagnostic Assessment and Treatment of Peripheral Nerve Tumors 2021. [DOI: 10.1007/978-3-030-77633-6_2] [Reference Citation Analysis]
36 Fukushima H, Yamasaki K, Sakaida M, Tsujio N, Okuno T, Ishii N, Okada K, Fujisaki H, Matsusaka Y, Sakamoto H, Yoneda A, Hara J, Inoue T. Rhabdoid tumor predisposition syndrome with renal tumor 10 years after brain tumor. Pathol Int 2021;71:155-60. [PMID: 33378586 DOI: 10.1111/pin.13056] [Reference Citation Analysis]
37 Ou C, Ho S. SMARCB1 (INI1)-deficient sinonasal carcinoma, basaloid subtype: First reported case in Taiwan and literature review. Human Pathology: Case Reports 2020;22:200423. [DOI: 10.1016/j.ehpc.2020.200423] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
38 Treece AL. Pediatric Renal Tumors: Updates in the Molecular Era. Surg Pathol Clin 2020;13:695-718. [PMID: 33183728 DOI: 10.1016/j.path.2020.08.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
39 Nacev BA, Jones KB, Intlekofer AM, Yu JSE, Allis CD, Tap WD, Ladanyi M, Nielsen TO. The epigenomics of sarcoma. Nat Rev Cancer 2020;20:608-23. [PMID: 32782366 DOI: 10.1038/s41568-020-0288-4] [Cited by in Crossref: 84] [Cited by in F6Publishing: 82] [Article Influence: 28.0] [Reference Citation Analysis]
40 Wang H, Tang D, Wu D, Tao C, Chen G, Ru W, Zhu K. Renal malignant tumor with the loss of INI1 expression and WT1 positive in a 3-year-old boy: a case report. Transl Androl Urol 2020;9:2275-80. [PMID: 33209693 DOI: 10.21037/tau-20-834] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
41 Dumont B, Lemelle L, Cordero C, Couloigner V, Bernard S, Cardoen L, Brisse HJ, Jehanno N, Fréneaux P, Helfre S, Rouffiange L, Réguerre Y, Orbach D. Esthesioneuroblastoma in children, adolescents and young adults. Bull Cancer 2020;107:934-45. [PMID: 32896369 DOI: 10.1016/j.bulcan.2020.06.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
42 Soldi R, Ghosh Halder T, Weston A, Thode T, Drenner K, Lewis R, Kaadige MR, Srivastava S, Daniel Ampanattu S, Rodriguez Del Villar R, Lang J, Vankayalapati H, Weissman B, Trent JM, Hendricks WPD, Sharma S. The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancer. PLoS One 2020;15:e0235705. [PMID: 32649682 DOI: 10.1371/journal.pone.0235705] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
43 Luu M, Halbert A, Yan A, Rubin A, McMahon P, Liang M, Vadeboncoeur S, Frieden IJ, Maguiness S. Cutaneous manifestations of congenital malignant rhabdoid tumor: Unusual papillomatous plaques and other skin presentations. Pediatr Dermatol 2020;37:645-50. [PMID: 32323351 DOI: 10.1111/pde.14175] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
44 Parker NA, Al-obaidi A, Deutsch JM. SMARCB1/INI1-deficient tumors of adulthood. F1000Res 2020;9:662. [DOI: 10.12688/f1000research.24808.1] [Reference Citation Analysis]
45 Msaouel P, Walker CL, Genovese G, Tannir NM. Molecular hallmarks of renal medullary carcinoma: more to c-MYC than meets the eye. Mol Cell Oncol 2020;7:1777060. [PMID: 32944636 DOI: 10.1080/23723556.2020.1777060] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
46 Regalbuto A, Tudosie A, Klenotic E. A metastatic distal-type epithelioid sarcoma: Case report and review. Int J Surg Case Rep 2020;71:144-6. [PMID: 32450373 DOI: 10.1016/j.ijscr.2020.04.096] [Reference Citation Analysis]
47 Msaouel P, Malouf GG, Su X, Yao H, Tripathi DN, Soeung M, Gao J, Rao P, Coarfa C, Creighton CJ, Bertocchio JP, Kunnimalaiyaan S, Multani AS, Blando J, He R, Shapiro DD, Perelli L, Srinivasan S, Carbone F, Pilié PG, Karki M, Seervai RNH, Vokshi BH, Lopez-Terrada D, Cheng EH, Tang X, Lu W, Wistuba II, Thompson TC, Davidson I, Giuliani V, Schlacher K, Carugo A, Heffernan TP, Sharma P, Karam JA, Wood CG, Walker CL, Genovese G, Tannir NM. Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary Carcinoma. Cancer Cell 2020;37:720-734.e13. [PMID: 32359397 DOI: 10.1016/j.ccell.2020.04.002] [Cited by in Crossref: 49] [Cited by in F6Publishing: 43] [Article Influence: 16.3] [Reference Citation Analysis]
48 Hu B, Lin JZ, Yang XB, Sang XT. The roles of mutated SWI/SNF complexes in the initiation and development of hepatocellular carcinoma and its regulatory effect on the immune system: A review. Cell Prolif 2020;53:e12791. [PMID: 32162380 DOI: 10.1111/cpr.12791] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 2.7] [Reference Citation Analysis]
49 Saunders J, Ingley K, Wang XQ, Harvey M, Armstrong L, Ng T, Dunham C, Bush J. Loss of BRG1 (SMARCA4) Immunoexpression in a Pediatric Non-Central Nervous System Tumor Cohort. Pediatr Dev Pathol 2020;23:132-8. [PMID: 31403913 DOI: 10.1177/1093526619869154] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
50 Soldi R, Halder TG, Weston A, Thode T, Drenner K, Lewis R, Kaadige MR, Srivastava S, Ampanattu SD, del Villar RR, Lang J, Vankayalapati H, Weissman B, Trent JM, Hendricks WP, Sharma S. The novel reversible LSD1 inhibitor SP-2577 promotes anti-tumor immunity in SWItch/Sucrose-NonFermentable (SWI/SNF) complex mutated ovarian cancer.. [DOI: 10.1101/2020.01.10.902528] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
51 Kubota Y, Arakawa Y, Sekiguchi M, Watanabe K, Hiwatari M, Kishimoto H, Nakazawa A, Yoshida A, Ogawa S, Hanada R, Oka A, Takita J, Koh K. A case of malignant rhabdoid tumor mimicking yolk sac tumor. Pediatr Blood Cancer 2019;66:e27784. [PMID: 31034722 DOI: 10.1002/pbc.27784] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
52 Abro B, Kaushal M, Chen L, Wu R, Dehner LP, Pfeifer JD, He M. Tumor mutation burden, DNA mismatch repair status and checkpoint immunotherapy markers in primary and relapsed malignant rhabdoid tumors. Pathology - Research and Practice 2019;215:152395. [DOI: 10.1016/j.prp.2019.03.023] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
53 Weissmiller AM, Wang J, Lorey SL, Howard GC, Martinez E, Liu Q, Tansey WP. Inhibition of MYC by the SMARCB1 tumor suppressor. Nat Commun 2019;10:2014. [PMID: 31043611 DOI: 10.1038/s41467-019-10022-5] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 10.5] [Reference Citation Analysis]
54 Langer LF, Ward JM, Archer TK. Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination. Elife 2019;8:e45672. [PMID: 31033435 DOI: 10.7554/eLife.45672] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 5.5] [Reference Citation Analysis]
55 Kilic AI, Mirza K, Mehrotra S, Pambuccian SE. A BAFfling liver aspirate: Metastatic high grade SMARCA4 deficient undifferentiated gastroesophageal junction carcinoma masquerading as a hematolymphoid malignancy. Diagn Cytopathol 2019;47:725-32. [PMID: 30897306 DOI: 10.1002/dc.24174] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
56 Blas L, Roberti J, Petroni J, Reniero L, Cicora F. Renal Medullary Carcinoma: a Report of the Current Literature. Curr Urol Rep 2019;20:4. [PMID: 30656488 DOI: 10.1007/s11934-019-0865-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
57 Pasricha S, Patnaik N, Kamboj M, Gupta G, Mehta A. Malignant extrarenal rhabdoid tumor of parapharyngeal space: A rare presentation. Int J Head Neck Pathol 2019;2:15. [DOI: 10.4103/jhnp.jhnp_4_19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
58 Paolini MA, Kipp BR, Sukov WR, Jenkins SM, Barr Fritcher EG, Aranda D, Santacruz KS, Al-dandan S, Fisher P, Mcdonald WC, Bondurant CP, Van Dyke Darkow G, Giannini C, Parisi JE, Jentoft ME, Raghunathan A. Sellar Region Atypical Teratoid/Rhabdoid Tumors in Adults: Clinicopathological Characterization of Five Cases and Review of the Literature. Journal of Neuropathology & Experimental Neurology 2018;77:1115-21. [DOI: 10.1093/jnen/nly091] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
59 Allard FD, Bell D, Stelow EB. Cytopathologic features of SMARCB1 (INI-1)-deficient sinonasal carcinoma: INI-1-Deficient Sinonasal Carcinoma. Cancer Cytopathology 2018;126:567-74. [DOI: 10.1002/cncy.22020] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]